Cargando…
Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022)
Time Determines the Combined Effect In article number 2200999, Lei Luo and co‐workers reveal the importance of “time” in the combination of photodynamic therapy and immune checkpoint blocking therapy. Immune checkpoint inhibitors (red cartoon people) need to intervene at the best timing of T cell in...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313500/ http://dx.doi.org/10.1002/advs.202270127 |
_version_ | 1784754094882160640 |
---|---|
author | Wu, Qinghua Chen, Yang Li, Qing Chen, Junmeng Mo, Junfeng Jin, Ming Yang, Qianzhan Rizzello, Loris Tian, Xiaohe Luo, Lei |
author_facet | Wu, Qinghua Chen, Yang Li, Qing Chen, Junmeng Mo, Junfeng Jin, Ming Yang, Qianzhan Rizzello, Loris Tian, Xiaohe Luo, Lei |
author_sort | Wu, Qinghua |
collection | PubMed |
description | Time Determines the Combined Effect In article number 2200999, Lei Luo and co‐workers reveal the importance of “time” in the combination of photodynamic therapy and immune checkpoint blocking therapy. Immune checkpoint inhibitors (red cartoon people) need to intervene at the best timing of T cell infiltration to exert the best anti‐tumor and anti‐metastatic efficacy. [Image: see text] |
format | Online Article Text |
id | pubmed-9313500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93135002022-07-27 Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022) Wu, Qinghua Chen, Yang Li, Qing Chen, Junmeng Mo, Junfeng Jin, Ming Yang, Qianzhan Rizzello, Loris Tian, Xiaohe Luo, Lei Adv Sci (Weinh) Cover Picture Time Determines the Combined Effect In article number 2200999, Lei Luo and co‐workers reveal the importance of “time” in the combination of photodynamic therapy and immune checkpoint blocking therapy. Immune checkpoint inhibitors (red cartoon people) need to intervene at the best timing of T cell infiltration to exert the best anti‐tumor and anti‐metastatic efficacy. [Image: see text] John Wiley and Sons Inc. 2022-07-25 /pmc/articles/PMC9313500/ http://dx.doi.org/10.1002/advs.202270127 Text en © 2022 Wiley‐VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Cover Picture Wu, Qinghua Chen, Yang Li, Qing Chen, Junmeng Mo, Junfeng Jin, Ming Yang, Qianzhan Rizzello, Loris Tian, Xiaohe Luo, Lei Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022) |
title | Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022) |
title_full | Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022) |
title_fullStr | Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022) |
title_full_unstemmed | Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022) |
title_short | Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022) |
title_sort | time rules the efficacy of immune checkpoint inhibitors in photodynamic therapy (adv. sci. 21/2022) |
topic | Cover Picture |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313500/ http://dx.doi.org/10.1002/advs.202270127 |
work_keys_str_mv | AT wuqinghua timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT chenyang timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT liqing timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT chenjunmeng timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT mojunfeng timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT jinming timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT yangqianzhan timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT rizzelloloris timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT tianxiaohe timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 AT luolei timerulestheefficacyofimmunecheckpointinhibitorsinphotodynamictherapyadvsci212022 |